Riboflavin as a tracer of medication compliance
- 1 September 1985
- journal article
- conference paper
- Published by Springer Nature in Journal of Behavioral Medicine
- Vol. 8 (3) , 287-299
- https://doi.org/10.1007/bf00870315
Abstract
Three experiments were conducted to evaluate the accuracy of urine ultraviolet fluorescent tests for riboflavin, which has been used as a tracer for medication compliance in several clinical drug trials. Observer accuracy in discriminating riboflavin-positive or negative urine samples was found to vary with the method of observation, dose of riboflavin, observer experience, and time postingestion. The results showed that, while the 5-mg dose used in previous clinical trials was too small to permit reliable assessment of compliance, larger doses of riboflavin could produce nearly 100% accuracy for minimally trained observers who used a matching-to-sample observation procedure. The findings are discussed in terms of the potential clinical and research applications of this type of simple but reliable compliance assessment procedure.This publication has 15 references indexed in Scilit:
- Effect of compliance for chronic asthmatic children.Journal of Consulting and Clinical Psychology, 1984
- Effect of compliance for chronic asthmatic children.Journal of Consulting and Clinical Psychology, 1984
- Can dropout and other noncompliance be minimized in a clinical trial? Report from the veterans administrative national heart, lung and blood institute cooperative study on antihypertensive therapy: Mild hypertensionControlled Clinical Trials, 1982
- A behavioral medicine perspective on adherence to long-term medical regimens.Journal of Consulting and Clinical Psychology, 1982
- A behavioral medicine perspective on adherence to long-term medical regimens.Journal of Consulting and Clinical Psychology, 1982
- BEHAVIORAL CONTROL OF MEDICINE COMPLIANCEJournal of Applied Behavior Analysis, 1978
- Propranolol in the treatment of essential hypertension.1977
- Propranolol in the Treatment of Essential HypertensionPublished by American Medical Association (AMA) ,1977
- Multiclinic controlled trial of bethanidine and guanethidine in severe hypertension.Circulation, 1977
- Effects Morbidity of Treatment on in HypertensionJAMA, 1970